期刊文献+

miR-145与肿瘤相关性研究进展 被引量:2

下载PDF
导出
摘要 微小RNA为一类长约19~25个核苷酸的内性非编码单链RNA.可抑制靶基因转录或蛋白翻译从而沉默靶基因的表达。大量研究表明,微小RNA作为原癌基因或抑癌基因在肿瘤的发生和发展过程中起重要作用。查阅国内外文献,近年来关于miR一145的研究更新较快。
出处 《实用医学杂志》 CAS 北大核心 2013年第23期3947-3948,共2页 The Journal of Practical Medicine
基金 福建省科技计划项目(编号:2012D021)
  • 相关文献

参考文献19

  • 1Xu N, Pag P, Pan G, et al. MiR-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells [J]. Ce11,2009, 137 (4) : 647 -658.
  • 2Yam N, Nog S, Mor T, et al. Tumor- suppressive miR-145 targets eatenin δ- 1 to regulate Wnt/β-eatenin signaling in human colon cancer cells [J]. Cancer Lett, 2013,335(2) : 332-342.
  • 3Dip N, Rei S T, Sro M, et al. Expression profile of miR-145 in urothelial bladder cancer [J]. Int Braz J Urol, 2013,39(1) :95-101.
  • 4Guo W, Ren D, Chert X, et al. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of miR-145 [J]. J Cell Biochem, 2013,114(7): 1606-1615.
  • 5张帅,武雅琴,冯冬杰,张治,蒋峰,尹荣,许林.miR-145通过下调OCT4基因抑制肺腺癌干细胞增殖[J].中国肺癌杂志,2011,14(4):317-322. 被引量:20
  • 6Wang R, Wang Z X, Rang J S, et al. MiR-451 functions as a tumor suppressor in human Non- small cell lung cancer by targeting ras-related protein 14 (RAB14) [J]. Oncogene, 2011,30(23) : 2644-2658.
  • 7Sla O, Svo M, Mic J, et al. MicroRNAs in colorectal cancer: translation of molecular biology into clinical application [J]. Molecular Cancer, 2009,14(8) : 102-115.
  • 8Yin Y, Yan Z P, Lu N N, et al. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N- RAS and IRS1 [J]. Biochim Biophys Acta, 2013,1829(2) : 239-247.
  • 9Dob K, Ste N, Har A K, et al. MiR- 145 targets the metalloprotease ADAMt7 and is suppressed in renal cell carcinoma patients [J]. Neoplasia, 2013,15(2) : 218-230.
  • 10Sac M, Zhu S, WU F, et al. p53 represses c-Myc through induction of the tumor suppressor miR-145 [J]. Proc Natl Acad Sci USA, 2009,106 (9) : 3207-3212.

二级参考文献13

  • 1Tysnes BB. Tumor-initiating and -propagating cells: cells that we would like to identify and control. Neoplasia, 2010, 12(7): 506-515.
  • 2Bertolini G, Roz L, Perego P, et al. Fiighly tumorigenic lung cancer CD133^+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci USA, 2009, 106(38): 16281-16286.
  • 3Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact.J Clin Oncol, 2009, 27(34): 5848-5856.
  • 4Sun Y, Bai Y, Zhang F, et al. miR- 126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun, 2010, 391(1): 1483-1489.
  • 5Rogler CE, Levoci L, Ader T, et al. MicroRNA-23b cluster microRNAs regu- late transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology, 2009, 50(2): 575-584.
  • 6Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative Ct method. Nat Protoc, 2008, 3(6): 1101-1108.
  • 7Hammond SM. RNAi, microRNAs, and human disease. Cancer Chemother Pharmacol, 2006, 58 (Suppl 1): 63-68.
  • 8Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 2006, 9(3): 189-198.
  • 9Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res, 2010, 70(1): 378-387.
  • 10Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006, 126(4): 663-676.

共引文献19

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部